HAMP and anemia (phenotype): The efficacy of hepcidin down-regulation through the targeting of the BMP receptor signaling pathway had been previously demonstrated with the use of our mouse model18,35,36, which represents a valuable tool to test new therapies for patients suffering from anemia associated with inappropriate high hepcidin levels.